Adam Scott Levy sold $346K of Mineralys Therapeutics (MLYS)

Executed Jan 12, disclosed Jan 13, 1 day later.

Value, as filed

$346K

10,758 sh × $32.14

Executed

Jan 12

the trade date, as filed

Disclosed

Jan 13

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AL Adam Scott Levy CFO and Secretary profile →

Adam Scott Levy (CFO and Secretary) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $5.3M of MLYS (116,948 sh across 7 lots, as filed), executed Nov 11 2025.

The name

MLYS Mineralys Therapeutics, Inc. MLYS · Healthcare · 50 filings in 24 months ticker →

Healthcare · Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Adam Scott Levy in MLYS

MLYSSALE Mineralys Therapeutics, Inc. $5.3M
116,948 sh across 7 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. $452K
10,758 sh across 2 lots
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. $1.1M
72,871 sh across 3 lots
Exec Jul 28 2025
Filed Jul 30 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. $155K
10,758 sh × $14.45
Exec Jul 11 2025
Filed Jul 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. $130K
10,757 sh × $12.06
Exec Apr 11 2025
Filed Apr 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. $146K
10,757 sh × $13.57
Exec Oct 11 2024
Filed Oct 15 2024 · 5:30 PM ET